pargyline has been researched along with Central Nervous System Origin Vertigo in 3 studies
Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| OLTMAN, JE | 1 |
| FRIEDMAN, S | 1 |
| KOHN, RM | 1 |
| HORLER, AR | 1 |
| WYNNE, NA | 1 |
3 other studies available for pargyline and Central Nervous System Origin Vertigo
| Article | Year |
|---|---|
PARGYLINE IN THE TREATMENT OF DEPRESSIVE ILLNESSES.
Topics: Antidepressive Agents; Antihypertensive Agents; Depression; Depressive Disorder; Hypotension; Imipra | 1963 |
NOCTURNAL ORTHOSTATIC SYNCOPE IN PARGYLINE THERAPY.
Topics: Antihypertensive Agents; Erectile Dysfunction; Humans; Hypotension; Hypotension, Orthostatic; Male; | 1964 |
HYPERTENSIVE CRISIS DUE TO PARGYLINE AND METARAMINOL.
Topics: Autonomic Nervous System Diseases; Drug Synergism; Drug Therapy; Headache; Hypertension; Metaraminol | 1965 |